Home Compare BMRN vs TTD
Stock Comparison · Comparison

BioMarin Pharmaceutical vs The Trade Desk: Which Stock Looks Stronger in 2026?

The Trade Desk holds the cleaner structural position, with the lead spread across growth and profitability. BioMarin Pharmaceutical still has the edge on stability, which keeps the comparison from looking entirely one-sided. Both sides have seen trend damage — neither carries a clear market edge right now. With both trends damaged, the structural comparison carries most of the weight here.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The lead is spread across growth and profitability, rather than sitting in one isolated gap. The Trade Desk, Inc. leads by 16 points on the overall comparison score.

Trajectory Similarity
0.66
Moderately similar
Peer-set rank: #5
within BioMarin Pharmaceutical Inc.'s functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The clearest structural overlap shows up in revenue stability and margin trend.

Similarity drivers
revenue stabilitymargin trend
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
BMRN
BioMarin Pharmaceutical Inc.
47
Peer-Score
Signal qualityHigh
vs
TTD
The Trade Desk, Inc.
63
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Score differences across key dimensions.

Dimension spread: BMRN vs TTD Profitability 48 86 Stability 42 6 Valuation 56 69 Growth 36 75 BMRN TTD
Gap Ranking
#1 Growth +39
#2 Profitability +38
#3 Stability +36
#4 Valuation +13
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for BMRN and TTD Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer BMRNTTD Relative valuation Structural strength

The Trade Desk, Inc. still looks stronger, and the price setup does not materially undermine that lead.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Growth
On growth, The Trade Desk, Inc. ranks near the top of the group; BioMarin Pharmaceutical Inc. sits in the weaker half.
Profitability
On profitability, the edge is clear — both rank well, but The Trade Desk, Inc. sits noticeably higher.
Growth — Dominant Gap
BMRN
36
TTD
75
Gap+39in favour of TTD

Earnings growth is one contributing factor within the growth lead.

What keeps the gap from being one-sided

Stability still tilts materially toward BioMarin Pharmaceutical Inc., which stops the result from looking dominant across the whole profile.

What this means for the comparison

The lead is built on both growth and profitability — though stability still provides a counterweight.

Explore full peer positioning in AssetNext

Break down the BMRN vs TTD comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Other comparisons with conflicting dimension signals

Explore how BMRN and TTD each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.